Market Movements: Rise in Novo Nordisk and Twilio, Decline in Boeing

This chapter delves into the dynamic stock market, emphasizing Novo Nordisk's impressive share rise spurred by positive early trial results for its obesity drug, Amacretin. Other highlights include Twilio's stock surge due to a promising profit outlook and Boeing's decline after disappointing quarterly earnings.